Your browser doesn't support javascript.
loading
Immunogenicity and safety of Advax™, a novel polysaccharide adjuvant based on delta inulin, when formulated with hepatitis B surface antigen: a randomized controlled Phase 1 study.
Gordon, David; Kelley, Peter; Heinzel, Susanne; Cooper, Peter; Petrovsky, Nikolai.
Affiliation
  • Gordon D; Department of Microbiology and Infectious Diseases, Flinders Medical Centre/Flinders University, Adelaide 5042, Australia.
  • Kelley P; Department of Microbiology and Infectious Diseases, Flinders Medical Centre/Flinders University, Adelaide 5042, Australia.
  • Heinzel S; Vaxine Pty Ltd, Bedford Park, Adelaide 5042, Australia.
  • Cooper P; Vaxine Pty Ltd, Bedford Park, Adelaide 5042, Australia; Cancer Research Laboratory, Australian National University Medical School at The Canberra Hospital, Garran, ACT 2605, Australia; John Curtin School of Medical Research, Australian National University, Acton, ACT 2601, Australia.
  • Petrovsky N; Vaxine Pty Ltd, Bedford Park, Adelaide 5042, Australia; Department of Endocrinology, Flinders Medical Centre/Flinders University, Adelaide 5042, Australia. Electronic address: nikolai.petrovsky@flinders.edu.au.
Vaccine ; 32(48): 6469-77, 2014 Nov 12.
Article in En | MEDLINE | ID: mdl-25267153
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Adjuvants, Immunologic / Hepatitis B Vaccines / Hepatitis B / Hepatitis B Surface Antigens / Inulin Type of study: Clinical_trials Limits: Adult / Female / Humans / Male Country/Region as subject: Oceania Language: En Journal: Vaccine Year: 2014 Type: Article Affiliation country: Australia
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Adjuvants, Immunologic / Hepatitis B Vaccines / Hepatitis B / Hepatitis B Surface Antigens / Inulin Type of study: Clinical_trials Limits: Adult / Female / Humans / Male Country/Region as subject: Oceania Language: En Journal: Vaccine Year: 2014 Type: Article Affiliation country: Australia